These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29921021)

  • 61. Peripheral T-cell lymphoma in children and adolescents: a single-institution experience.
    Al Mahmoud R; Weitzman S; Schechter T; Ngan B; Abdelhaleem M; Alexander S
    J Pediatr Hematol Oncol; 2012 Nov; 34(8):611-6. PubMed ID: 23042011
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hepatosplenic gamma/delta T-cell lymphoma in bone marrow. A sinusoidal neoplasm with blastic cytologic features.
    Vega F; Medeiros LJ; Bueso-Ramos C; Jones D; Lai R; Luthra R; Abruzzo LV
    Am J Clin Pathol; 2001 Sep; 116(3):410-9. PubMed ID: 11554170
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Successful treatment of advanced natural killer cell lymphoma with high-dose chemotherapy and syngeneic peripheral blood stem cell transplantation.
    Nawa Y; Takenaka K; Shinagawa K; Deguchi S; Matsumura N; Koyama S; Hiramatsu Y; Omoto E; Yoshino T; Harada M
    Bone Marrow Transplant; 1999 Jun; 23(12):1321-2. PubMed ID: 10414923
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Allogeneic stem cell transplantation for hepatosplenic gammadelta T-cell lymphoma.
    Konuma T; Ooi J; Takahashi S; Tomonari A; Tsukada N; Kobayashi T; Sato A; Tojo A; Asano S
    Leuk Lymphoma; 2007 Mar; 48(3):630-2. PubMed ID: 17454612
    [No Abstract]   [Full Text] [Related]  

  • 65. Hepatosplenic T-cell lymphoma in a 47-year-old Crohn's disease patient on thiopurine monotherapy.
    van de Meeberg MM; Derikx LA; Sinnige HA; Nooijen P; Schipper DL; Nissen LH
    World J Gastroenterol; 2016 Dec; 22(47):10465-10470. PubMed ID: 28058028
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Primary breast lymphoma--a report of 27 cases with literature review].
    Cao YB; Wang SS; Huang HQ; Xu GC; He YJ; Guan ZZ; Lin TY
    Ai Zheng; 2007 Jan; 26(1):84-9. PubMed ID: 17222374
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Successful cord blood transplantation for refractory gamma-delta hepatosplenic T-cell lymphoma developed during treatment of Crohn's disease].
    Saito A; Nara M; Fujishima T; Kuroki W; Yamashita T; Kobayashi T; Ikeda S; Kitadate A; Kameoka Y; Takahashi N
    Rinsho Ketsueki; 2024; 65(1):41-46. PubMed ID: 38311388
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Incidence, clinical findings, and survival of hepatosplenic T-cell lymphoma in the United States.
    Durani U; Go RS
    Am J Hematol; 2017 Jun; 92(6):E99-E101. PubMed ID: 28263402
    [No Abstract]   [Full Text] [Related]  

  • 69. Hepatosplenic T-cell lymphoma: A case series.
    Ashmore P; Patel M; Vaughan J; Wiggill T; Willem P; van den Berg E; Philip V; Lakha A
    Hematol Oncol Stem Cell Ther; 2015 Jun; 8(2):78-84. PubMed ID: 25450840
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Treatment outcome and prognosis of autologous hematopoietic stem cell transplantation combined with high dose radiotherapy/chemotherapy in 22 patients with nasal NK/T cell lymphoma].
    Cui XZ; Wang HQ; Liu XM; Zhang HL; Li W
    Zhonghua Xue Ye Xue Za Zhi; 2007 Sep; 28(9):609-11. PubMed ID: 18246818
    [TBL] [Abstract][Full Text] [Related]  

  • 71. High-dose chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: complete response at transplant predicts survival.
    Kim MK; Kim S; Lee SS; Sym SJ; Lee DH; Jang S; Park CJ; Chi HS; Huh J; Suh C
    Ann Hematol; 2007 Jun; 86(6):435-42. PubMed ID: 17256144
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Post-transplant hepatosplenic T-cell lymphoma successfully treated with HyperCVAD regimen.
    Tey SK; Marlton PV; Hawley CM; Norris D; Gill DS
    Am J Hematol; 2008 Apr; 83(4):330-3. PubMed ID: 17876769
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Crohn's disease, hepatosplenic T-cell lymphoma and no biological therapy: are we barking up the wrong tree?
    Moran G; Dillon J; Green J
    Inflamm Bowel Dis; 2009 Sep; 15(9):1281-2. PubMed ID: 19067412
    [No Abstract]   [Full Text] [Related]  

  • 74. Hepatosplenic gammadelta T-cell lymphoma: complete response induced by treatment with pentostatin.
    Iannitto E; Barbera V; Quintini G; Cirrincione S; Leone M
    Br J Haematol; 2002 Jun; 117(4):995-6. PubMed ID: 12060145
    [No Abstract]   [Full Text] [Related]  

  • 75. [High-dose chemotherapy with autologous bone marrow transplantation: 11 years' experience in Zurich].
    Jost LM; Honegger HP; Stahel RA
    Schweiz Med Wochenschr; 2000 Jan; 130(3):60-9. PubMed ID: 10683881
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Treatment outcomes and prognostic analyses of relapsed or refractory T-cell non-Hodgkin's lymphoma].
    Gao Y; Huang HQ; Lin XB; Cai QQ; Pan ZH; Wang BF; Bu Q
    Ai Zheng; 2007 Aug; 26(8):909-13. PubMed ID: 17697558
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Successful treatment of disseminated nasal NK/T-cell lymphoma using double autologous peripheral blood stem cell transplantation.
    Sasaki M; Matsue K; Takeuchi M; Mitome M; Hirose Y
    Int J Hematol; 2000 Jan; 71(1):75-8. PubMed ID: 10729998
    [TBL] [Abstract][Full Text] [Related]  

  • 78. High-dose chemotherapy with autologous stem cell transplantation in extranodal NK/T-cell lymphoma: a retrospective comparison with non-transplantation cases.
    Kim HJ; Bang SM; Lee J; Kwon HC; Suh C; Kim HJ; Lee JH; Ryoo BY; Park YH; Kwon JM; Oh SY; Lee HR; Kim K; Jung CW; Park K; Kim WS
    Bone Marrow Transplant; 2006 May; 37(9):819-24. PubMed ID: 16547486
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Autologous stem cell transplantation with thiotepa, busulfan, and cyclophosphamide (TBC) conditioning in patients with CNS involvement by non-Hodgkin lymphoma.
    Cote GM; Hochberg EP; Muzikansky A; Hochberg FH; Drappatz J; McAfee SL; Batchelor TT; LaCasce AS; Fisher DC; Abramson JS; Armand P; Chen YB
    Biol Blood Marrow Transplant; 2012 Jan; 18(1):76-83. PubMed ID: 21749848
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Use of PEG-asparaginase in a case of Hepatosplenic γδ T-cell lymphoma with long-term remission after stem cell transplantation.
    Sun K; Sanchez CG; Pingali SR; Iyer S
    Ecancermedicalscience; 2018; 12():872. PubMed ID: 30483352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.